Complement 3 glomerulopathy

Clinical trials for Complement 3 glomerulopathy explained in plain language.

Never miss a new study

Get alerted when new Complement 3 glomerulopathy trials appear

Sign up with your email to follow new studies for Complement 3 glomerulopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

New drug iptacopan studied for rare kidney disease C3G

Disease control Not yet recruiting

This study looks back at the experiences of 35 adults with a rare kidney disease called C3G who received the drug iptacopan through a special early access program in Spain. Researchers will collect information on patient health, lab results, and how the disease responds to treatm…

Matched conditions: COMPLEMENT 3 GLOMERULOPATHY

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Complement 3 glomerulopathy

Get alerted when new Complement 3 glomerulopathy trials appear

New drug iptacopan studied for rare kidney disease C3G